Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Frontiers in Neuroscience
|
October 7, 2015
From UBE3A to Angelman syndrome: a substrate perspective
Gabrielle L Sell, Seth S Margolis
Trends in Neurosciences
|
September 5, 2020
Protecting Connections from Synapse Elimination
Gabrielle L Sell, A Kimberley McAllister
Behavioral Neuroscience
|
July 27, 2011
Social regulation of serotonin in the auditory midbrain
Ian C Hall, Gabrielle L Sell, Laura M Hurley
The Journal of Clinical Investigation
|
March 28, 2017
Reducing expression of synapse-restricting protein Ephexin5 ameliorates Alzheimer's-like impairment in mice
Gabrielle L Sell, Thomas B Schaffer, Seth S Margolis
Biorxiv : the Preprint Server for Biology
|
March 18, 2024
Glutamate signaling and neuroligin/neurexin adhesion play opposing roles that are mediated by major histocompatibility complex I molecules in cortical synapse formation
Gabrielle L Sell, Stephanie L Barrow, A Kimberley McAllister
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 18, 2024
Glutamate Signaling and Neuroligin/Neurexin Adhesion Play Opposing Roles That Are Mediated by Major Histocompatibility Complex I Molecules in Cortical Synapse Formation
Gabrielle L Sell, Stephanie L Barrow, A Kimberley McAllister
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
June 5, 2015
Angelman Syndrome
Seth S Margolis, Gabrielle L Sell, Mark A Zbinden, et al.
Behavioural Brain Research
|
September 13, 2011
Stress-evoked increases in serotonin in the auditory midbrain do not directly result from elevations in serum corticosterone
Ian C Hall, Gabrielle L Sell, Emily M Chester, et al.
Plos One
|
January 6, 2017
Early-Life Social Isolation Influences Mouse Ultrasonic Vocalizations during Male-Male Social Encounters
Sarah M Keesom, Caitlyn J Finton, Gabrielle L Sell, et al.
Expert Opinion on Therapeutic Targets
|
February 28, 2019
The emergence of Ephexin5 as a therapeutic target in Alzheimer's disease
Emily K Cook, Gabrielle L Sell, Thomas B Schaffer, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Frontiers in Neuroscience
|
October 7, 2015
From UBE3A to Angelman syndrome: a substrate perspective
Gabrielle L Sell, Seth S Margolis
Trends in Neurosciences
|
September 5, 2020
Protecting Connections from Synapse Elimination
Gabrielle L Sell, A Kimberley McAllister
Behavioral Neuroscience
|
July 27, 2011
Social regulation of serotonin in the auditory midbrain
Ian C Hall, Gabrielle L Sell, Laura M Hurley
The Journal of Clinical Investigation
|
March 28, 2017
Reducing expression of synapse-restricting protein Ephexin5 ameliorates Alzheimer's-like impairment in mice
Gabrielle L Sell, Thomas B Schaffer, Seth S Margolis
Biorxiv : the Preprint Server for Biology
|
March 18, 2024
Glutamate signaling and neuroligin/neurexin adhesion play opposing roles that are mediated by major histocompatibility complex I molecules in cortical synapse formation
Gabrielle L Sell, Stephanie L Barrow, A Kimberley McAllister
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 18, 2024
Glutamate Signaling and Neuroligin/Neurexin Adhesion Play Opposing Roles That Are Mediated by Major Histocompatibility Complex I Molecules in Cortical Synapse Formation
Gabrielle L Sell, Stephanie L Barrow, A Kimberley McAllister
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
June 5, 2015
Angelman Syndrome
Seth S Margolis, Gabrielle L Sell, Mark A Zbinden, et al.
Behavioural Brain Research
|
September 13, 2011
Stress-evoked increases in serotonin in the auditory midbrain do not directly result from elevations in serum corticosterone
Ian C Hall, Gabrielle L Sell, Emily M Chester, et al.
Plos One
|
January 6, 2017
Early-Life Social Isolation Influences Mouse Ultrasonic Vocalizations during Male-Male Social Encounters
Sarah M Keesom, Caitlyn J Finton, Gabrielle L Sell, et al.
Expert Opinion on Therapeutic Targets
|
February 28, 2019
The emergence of Ephexin5 as a therapeutic target in Alzheimer's disease
Emily K Cook, Gabrielle L Sell, Thomas B Schaffer, et al.
Page
of 2